Extended Data Fig. 1: Structures of 139 defined glycans used in CaR-ESI-MS screening against RBD and S protein.
From: Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2
These glycans comprise 9 groups: Lewis antigens, blood group ABH antigens, antigen-related glycans, globo-series glycans, ganglioside oligosaccharides, human milk oligosaccharides, Neu5Acα2-6 linked glycans, rhamnose-containing glycans (Library P) and others.
